Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV–PCV2–SIV clinical infection model 2–3-months post vaccination
T. Opriessnig, A.R. Patterson, D.M. Madson, N. Pal, P.G. HalburТом:
27
Рік:
2009
Мова:
english
DOI:
10.1016/j.vaccine.2008.11.105
Файл:
PDF, 227 KB
english, 2009